Excerpts

Similarly, within-group changes in the 50-mg group indicated a statistical trend ( p = 0.051) for peak extension power values to change across time.

This effect remained significant for r = 0.9 (SMD = 0.52, p = 0.032) or almost significant for 0.5 (SMD = 0.26, p = 0.051), but differences did not reach statistical significance for r =0.2 (SMD = 0.21, p = 0.112).

In non-users, there were non-significant decreases in cardiovascular events in all treatment groups compared to placebo, and the reduction bordered on significance in the adjusted model for the combined EPA + DHA + ALA group ( p = 0.051).

The mean fullness score for the PGX (granules) meal was also significantly higher at time points 15, 30, 45, and 60 min (5.9, 5.7, 4.9, 4.3 respectively) than for the WD meal (3.5, 2.8, 2.2, 1.4 respectively) (all p < 0.01) and showed a strong trend towards being higher at 90 min ( p = 0.051).

The decrease was statistically significant in the LFD group ( p = 0.002), while the traditional IBS diet group showed a trend toward improvement ( p = 0.051).

For leucine AUC, a significant treatment effect was found ( p < 0.001), while the time effect approached significance ( p = 0.051).

As expected, urinary glucose was higher in individuals with T2D (2.31 ± 6.21 g/L) compared to those with preDM (0.08 ± 0.05 g/L) and NonDM (0.45 ± 1.42 g/L), with a p -value close to significance ( p = 0.051).

the control group at week 14, with it being very close to statistical significance ( p = 0.051). 3.5.

Effect of MVMS on DBP A marginally significant lowering effect of MVMS on DBP was observed: The overall effect size (WMD) was −0.71 mmHg (95% CI, −1.43 to 0.00 mmHg; p = 0.051) ( Figure 4 ).

Fasting C-peptide levels showed a marginal trend toward higher values on the day of pelemir-enriched bread consumption (median: 2.1 [0.7–7.1] ng/mL vs. 2.0 [0.6–4.1] ng/mL; p = 0.051).

LNFP III exhibited a gradual decrease over time in Se+/Le+ and Se−Le+ milk ( p < 0.001), with only marginally significant change observed in Se+/Le− milk ( p = 0.051).

However, it is important to note that some of the effect sizes, such as the borderline significant total indirect effect observed between TC and ln(HOMA) ( p = 0.051), should be interpreted cautiously.

When adjusted, 3MS scores did not show a significant association with serum calcium, intact PTH, fetuin-A, T50, the use of cinacalcet, or the use of VDRAs, although the association between 3MS and the use of phosphate binders was at a borderline significance ( p = 0.051).

The Begg’s test of 25(OH)D results showed borderline significance ( p = 0.051), while the Egger’s test showed statistical significance ( p = 0.007) with the funnel plot presenting an asymmetrical appearance.

Similarly, there was a significant reduction in TNF-α, the other primary endpoints after the egg breakfast period, while IL-6 was, was borderline significant ( p = 0.051).

FGF21 showed a trend ( p = 0.051) in overall change in participants following the LCHF diet after decreasing from a median (IQR) of 148.16 (203.49) to 99.4 (92.43) pg/mL at week 4 and increasing again to 167.38 (152.08) pg/mL at week 8, with post-hoc analysis reporting a trend ( p = 0.069) between baseline and week 4, whereas no change was observed in HCLF.

Differences in the consumption per year of cookies were also detected; the differences between groups were very close to statistical significance ( p = 0.0510), with higher consumption in children with ASD than in typically developing peers.

Body Composition After about eight months of nutritional counselling, the adolescent athletes increased their MAMC, while and showed a trend towards significance to increase their lean mass ( p = 0.051).

We observed a strong trend ( p = 0.051) towards an interaction between treatments.

In follow-up, there was a borderline significant result in cognitive SR skills when comparing low PEL intervention and control groups ( p = 0.051).

The main effect of Group was only marginally significant (F 1,111 = 3.88; p = 0.051; pƞ 2 = 0.03).

After adjustment for multiple comparisons, reported ratings (and thus intensity of symptom) of anxiety approached significance at day 17 (1.0 ± 0.4, p = 0.051) and were significantly lower at the intervention endpoint (1.0 ± 0.3, p = 0.048) as compared to baseline (3.3 ± 1.0).

The difference in PSS-10 scores approached significance (U = 5628.50, Z = −1.95, p = 0.052), with lower scores observed in supplement users.

The association of ethnicity with absolute servings of yogurt was not quite significant ( p = 0.052).

Within the groups, the low PEL control group decreased their cognitive SR skills (borderline significance, p = 0.052).